Beren Therapeutics at AES 2026

Dec 4–8, 2026 Denver, CO ~6.2k attendees Website

Beren Therapeutics at AES 2026 in Denver: Booth 807, 808.

OrganizationAES 2026 Attendance
Beren Therapeutics
Thousand Oaks, CA
Epilepsy drug and therapy developers
Drug developer organized as a public benefit corporation; its lead investigational medicine is adrabetadex.
Booth
Exhibiting at Booth 807, 808
Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm

Explore the full AES 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Denver. Leave your work email and we’ll be in touch.

Privacy

Download the full AES 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Beren Therapeutics

Tell us what you sell and we’ll find the people at Beren Therapeutics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the American Epilepsy Society. Organization details are derived from AES’s published exhibitor list and online program, and each exhibitor’s own profile and website. Submit a correction